Last reviewed · How we verify

NCT07124689

Relationship Between Central Sensitization Levels and Treatment Outcomes in Frozen Shoulder Treatment

Completed Last updated 31 December 2025
What this trial tests

trial testing Treatment outcome in Frozen Shoulder in 87 participants. Completed in 15 December 2025.

Timeline
9 August 2025
Primary endpoint
15 November 2025
15 December 2025

Quick facts

Lead sponsorSultan 1. Murat State Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment87
Start date9 August 2025
Primary completion15 November 2025
Estimated completion15 December 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Sultan 1. Murat State Hospital

Who can join

Adults 18 to 75, any sex, with Frozen Shoulder or Central Sensitisation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to evaluate the relationship between treatment outcomes and central sensitization levels in patients who received intra-articular injections for frozen shoulder.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Treatment outcome

Trials testing the same drug.

Other recruiting trials for Frozen Shoulder

Currently open trials in the same condition.

Other Sultan 1. Murat State Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07124689.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing